|
FY2021
12 months to Jan 31, 2021
|
FY2020
12 months to Jan 31, 2020
|
FY2019
12 months to Jan 31, 2019
|
FY2018
12 months to Jan 31, 2018
|
FY2017
12 months to Jan 31, 2017
|
|
|---|---|---|---|---|---|
| OPERATING ACTIVITIES: | |||||
| Net income | |||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||
| Depreciation | |||||
| Amortization of intangible assets | |||||
| Long-lived asset impairment loss | |||||
| Change in fair value of acquisition-related contingent consideration | |||||
| Loss from equity investments | |||||
| Gain from sale of equity method investments | |||||
| Deferred income taxes | |||||
| Share-based compensation expense | |||||
| Other operating activities, net | |||||
| Change in operating assets and liabilities | |||||
| Net cash provided by operating activities | |||||
| INVESTING ACTIVITIES: | |||||
| Capital expenditures | |||||
| Payments related to business acquisitions, net of cash acquired | |||||
| Proceeds from sale or maturities of investments | |||||
| Purchases of investments | |||||
| Proceeds (disbursements) from sale of assets, settlement of liabilities | |||||
| Proceeds from sale of assets | |||||
| Other investing activities, net | |||||
| Net cash used in investing activities | |||||
| FINANCING ACTIVITIES: | |||||
| Dividends paid | |||||
| Payments for common shares repurchased | |||||
| Proceeds from debt | |||||
| Repayments of debt | |||||
| Payments for redeemable noncontrolling interest | |||||
| Payment of acquisition-related contingent liabilities | |||||
| Restricted stock units vested and issued, net of taxes | |||||
| Employee stock option exercises net of tax benefit | |||||
| Other financing activities, net | |||||
| Net cash used in financing activities | |||||
| Effect of exchange rate changes on cash | |||||
| Net increase (decrease) in cash and cash equivalents | |||||
| Cash and cash equivalents at beginning of year | |||||
| Cash and cash equivalents at end of year | |||||
Loading...
